Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | V514L |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | FGFR2 V514L lies within the protein kinase domain of the Fgfr2 protein (UniProt.org). V514L has not been characterized in the scientific literature and therefore, its effect on Fgfr2 protein function is unknown (PubMed, Nov 2024). |
Associated Drug Resistance | |
Category Variants Paths |
FGFR2 mutant FGFR2 V514L |
Transcript | NM_000141.5 |
gDNA | chr10:g.121500847C>G |
cDNA | c.1540G>C |
Protein | p.V514L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017015920 | chr10:g.121500901C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
NM_000141.4 | chr10:g.121500847C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
NM_001320658.1 | chr10:g.121500841C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
XM_006717708.4 | chr10:g.121500901C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
NM_000141 | chr10:g.121500847C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
NM_001320658 | chr10:g.121500841C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
XM_017015920.2 | chr10:g.121500901C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
XM_006717708.3 | chr10:g.121500901C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
NM_000141.5 | chr10:g.121500847C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
XM_006717708 | chr10:g.121500901C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
XM_017015920.3 | chr10:g.121500901C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
NM_001320658.2 | chr10:g.121500841C>G | c.1540G>C | p.V514L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR2 V514L | lung non-small cell carcinoma | no benefit | Fexagratinib | Case Reports/Case Series | Actionable | In a Phase II trial (NLMT), AZD4547 treatment did not result in a confirmed response or durable clinical benefit in a patient with non-small cell lung cancer harboring FGFR2 V515L (corresponds to V514L in the canonical isoform (PMID: 32669708, NCT02664935). | 32669708 |